Market Overview:
The global rat model market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the rat model market can be attributed to the increasing use of rat models in research and drug development, rising prevalence of chronic diseases, and growing demand for personalized medicine. Based on type, the global rat model market is segmented into knockout, outbred, inbred, hybrid, immunodeficient, and conditioned rats. The knockout rats segment is expected to account for the largest share of the global rat model market in 2018.
Product Definition:
Rat model is a animal model used for scientific research. The rat has been found to be useful in studying many human diseases, including cancer, heart disease, and diabetes.
Knockout:
Knockout is a technique used in genetic engineering to remove or replace a gene of interest. It's major use is in the study of human disease-associated genes. The method involves creating mutations in the DNA sequence that codes for the protein, which can be tested for their effect on protein production and activity. If they have no effect, then it can be concluded that this particular gene does not code for a functional protein and hence cannot cause disease symptoms when disrupted.
Outbred:
Outbred rats are widely used in toxicology and carcinogenicity studies. These rats have a uniform genetic makeup, which makes them more prone to develop the same disease condition as that of human beings. The most commonly used outbred rat is Wistar albino male by name.
Outbred rat model market is segmented on the basis of application into pharmacokinetics/pharmacodynamics (PK/PD), animal safety assurance, preclinical toxicity testing,.
Application Insights:
Oncology accounted for the largest share of revenue in 2016. The segment is expected to maintain its dominance during the forecast period due to rising prevalence of cancer and increasing government funding for cancer research. Knockout mice have proved to be an effective tool in oncology research and are being used across several applications such as tumor screening, biomarker discovery, development of novel therapeutics, and genetic analysis.
The neurology segment is also expected to grow rapidly during the forecast period owing to extensive R&D investments by major players such as Biogen Inc., Novartis Institutes Ltd., sanofi-aventis ULC (a member of Sanofi Pasteur), Pfizer laboratories, EMD Millipore Corporation (a Merck KGaA company), etc. towards developing new rat models that can mimic human neurological disorders for diagnostic purposes as well as serve as a potential therapeutic target itself.
Regional Analysis:
North America dominated the global rat model market in 2017. This can be attributed to the presence of several research entities and universities involved in drug discovery & development, which is funding most of the rat model projects undertaken by them. In addition, increasing government initiatives for cancer research and rising prevalence of chronic diseases are some other factors contributing toward market growth in this region. For instance, as per statistics published by American Cancer Society (ACS), around 2 million new cases were diagnosed in U.S.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to an increase number of contract agreements signed between pharmaceutical companies and countries such as Japan & China pertaining towards toxicology studies along with other oncology models like breast tumor induction using hormone responsive rats etc.
Growth Factors:
- Increasing research and development in the field of rat model technology
- Growing demand for personalized medicine and preclinical research services
- Rising number of CRO's and CMOs providing rat model services
- Proliferation of contract research organizations (CROs) that offer specialized rodent models 5. Technological advancements that make rat models more accurate, reliable, and user-friendly
Scope Of The Report
Report Attributes
Report Details
Report Title
Rat Model Market Research Report
By Type
Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned
By Application
Oncology, Neurology, Immunology, Toxicology, Other
By Companies
genOway, Charles River Laboratories International, Inc., Envigo, Covance Inc., Horizon Discovery Group plc, Janvier Labs, Taconic Biosciences, Inc., Biomedical Research Models (Biomere), Transpogen Biopharmaceutical, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Rat Model Market Report Segments:
The global Rat Model market is segmented on the basis of:
Types
Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Neurology, Immunology, Toxicology, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- genOway
- Charles River Laboratories International, Inc.
- Envigo
- Covance Inc.
- Horizon Discovery Group plc
- Janvier Labs
- Taconic Biosciences, Inc.
- Biomedical Research Models (Biomere)
- Transpogen Biopharmaceutical, Inc.
Highlights of The Rat Model Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Knockout
- Outbred
- Inbred
- Hybrid
- Immunodeficient
- Conditioned
- By Application:
- Oncology
- Neurology
- Immunology
- Toxicology
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rat Model Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A rat model is a research method that uses rats to study human diseases or conditions.
Some of the major players in the rat model market are genOway, Charles River Laboratories International, Inc., Envigo, Covance Inc., Horizon Discovery Group plc, Janvier Labs, Taconic Biosciences, Inc., Biomedical Research Models (Biomere), Transpogen Biopharmaceutical, Inc..
The rat model market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rat Model Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rat Model Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rat Model Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rat Model Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rat Model Market Size & Forecast, 2018-2028
4.5.1 Rat Model Market Size and Y-o-Y Growth
4.5.2 Rat Model Market Absolute $ Opportunity
Chapter 5 Global Rat Model Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Rat Model Market Size Forecast by Type
5.2.1 Knockout
5.2.2 Outbred
5.2.3 Inbred
5.2.4 Hybrid
5.2.5 Immunodeficient
5.2.6 Conditioned
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Rat Model Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Rat Model Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Neurology
6.2.3 Immunology
6.2.4 Toxicology
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rat Model Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rat Model Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Rat Model Analysis and Forecast
9.1 Introduction
9.2 North America Rat Model Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Rat Model Market Size Forecast by Type
9.6.1 Knockout
9.6.2 Outbred
9.6.3 Inbred
9.6.4 Hybrid
9.6.5 Immunodeficient
9.6.6 Conditioned
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Rat Model Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Neurology
9.10.3 Immunology
9.10.4 Toxicology
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Rat Model Analysis and Forecast
10.1 Introduction
10.2 Europe Rat Model Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Rat Model Market Size Forecast by Type
10.6.1 Knockout
10.6.2 Outbred
10.6.3 Inbred
10.6.4 Hybrid
10.6.5 Immunodeficient
10.6.6 Conditioned
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Rat Model Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Neurology
10.10.3 Immunology
10.10.4 Toxicology
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Rat Model Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Rat Model Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Rat Model Market Size Forecast by Type
11.6.1 Knockout
11.6.2 Outbred
11.6.3 Inbred
11.6.4 Hybrid
11.6.5 Immunodeficient
11.6.6 Conditioned
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Rat Model Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Neurology
11.10.3 Immunology
11.10.4 Toxicology
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Rat Model Analysis and Forecast
12.1 Introduction
12.2 Latin America Rat Model Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Rat Model Market Size Forecast by Type
12.6.1 Knockout
12.6.2 Outbred
12.6.3 Inbred
12.6.4 Hybrid
12.6.5 Immunodeficient
12.6.6 Conditioned
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Rat Model Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Neurology
12.10.3 Immunology
12.10.4 Toxicology
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Rat Model Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Rat Model Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Rat Model Market Size Forecast by Type
13.6.1 Knockout
13.6.2 Outbred
13.6.3 Inbred
13.6.4 Hybrid
13.6.5 Immunodeficient
13.6.6 Conditioned
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Rat Model Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Neurology
13.10.3 Immunology
13.10.4 Toxicology
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rat Model Market: Competitive Dashboard
14.2 Global Rat Model Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 genOway
14.3.2 Charles River Laboratories International, Inc.
14.3.3 Envigo
14.3.4 Covance Inc.
14.3.5 Horizon Discovery Group plc
14.3.6 Janvier Labs
14.3.7 Taconic Biosciences, Inc.
14.3.8 Biomedical Research Models (Biomere)
14.3.9 Transpogen Biopharmaceutical, Inc.
